BioNTech SE 22UA

XET: 22UA | ISIN: US09075V1026   12/11/2024
101,60 EUR (-0,39%)
(-0,39%)   12/11/2024

27 mei 2024 · MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnership · Persbericht

12 maart 2024 · Class Action Filed Against BioNTech SE (BNTX) - March 12, 2024 Deadline to Join - Contact Levi & Korsinsky · Persbericht

7 maart 2024 · Kessler Topaz Meltzer & Check, LLP Reminds BioNTech SE Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm · Persbericht

6 maart 2024 · Levi & Korsinsky Notifies Shareholders of BioNTech SE(BNTX) of a Class Action Lawsuit and an Upcoming Deadline · Persbericht

28 februari 2024 · BNTX Investors Have Opportunity to Lead BioNTech SE Securities Fraud Lawsuit · Persbericht

27 februari 2024 · Investors in BioNTech SE Should Contact Levi & Korsinsky Before March 12, 2024 to Discuss Your Rights - BNTX · Persbericht

26 februari 2024 · Attention BNTX Shareholders: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed against BioNTech SE (BNTX) and Encourages Investors to Contact the Firm · Persbericht

23 februari 2024 · Shareholders that lost money on BioNTech SE (BNTX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More · Persbericht

21 februari 2024 · BIONTECH SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In BioNTech To Contact Him Directly To Discuss Their Options · Persbericht

20 februari 2024 · Lost Money on BioNTech SE(BNTX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky · Persbericht

17 februari 2024 · Kessler Topaz Meltzer & Check, LLP Reminds BNTX Investors of March 12, 2024 Deadline in Securities Fraud Class Action against of BioNTech SE (BNTX) and Urges Investors with Substantial Losses to Contact the Firm · Persbericht

16 februari 2024 · BIONTECH SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In BioNTech To Contact Him Directly To Discuss Their Options · Persbericht

16 februari 2024 · Shareholders that lost money on BioNTech SE (BNTX) should contact Levi & Korsinsky about pending Class Action - BNTX · Persbericht

14 februari 2024 · BNTX Investors Have Opportunity to Lead BioNTech SE Securities Fraud Lawsuit · Persbericht

13 februari 2024 · March 12, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against BNTX · Persbericht

9 februari 2024 · Biontech Investor Deadline Approaching · Persbericht

8 februari 2024 · Kessler Topaz Meltzer & Check, LLP Reminds BioNTech SE Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors to Contact the Firm · Persbericht

2 februari 2024 · Biontech Shareholder Action Reminder · Persbericht

30 januari 2024 · BioNTech SE (BNTX) Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds BNTX Investors of Securities Fraud Class Action Lawsuit Filed On Their Behalf · Persbericht

25 januari 2024 · Biontech Investor Deadline Approaching · Persbericht

Mijn selecties